Adding Medication to Wellbutrin for Anxiety
Add an SSRI (such as sertraline, fluoxetine, or paroxetine) or an SNRI (such as venlafaxine) to bupropion for anxiety treatment. These combinations are supported by FDA labeling showing bupropion can be safely combined with these agents, and clinical evidence demonstrates both improved anxiety outcomes and tolerability 1, 2.
Primary Recommendation: SSRIs as First-Line Addition
Start with an SSRI added to your current bupropion regimen. The evidence strongly supports this approach:
- Sertraline is particularly well-studied in combination with bupropion, showing improvements in both depression and anxiety symptoms 2
- Fluoxetine and paroxetine are also explicitly mentioned in FDA labeling as compatible combinations, though you may need to reduce their doses since bupropion inhibits CYP2D6 and can increase SSRI levels 1
The FDA label specifically notes that bupropion increases concentrations of SSRIs including paroxetine, fluoxetine, and sertraline through CYP2D6 inhibition 1. Start SSRIs at lower doses when combining (consider 50% dose reduction for paroxetine or fluoxetine) and titrate based on response and tolerability.
Alternative: SNRIs (Venlafaxine)
Venlafaxine is another evidence-based option for augmenting bupropion for anxiety 2. However, be aware that bupropion significantly alters venlafaxine pharmacokinetics—it increases venlafaxine levels while decreasing its active metabolite O-desmethylvenlafaxine 2. Monitor closely for side effects and consider starting at lower venlafaxine doses.
Clinical Evidence Supporting These Combinations
A 2002 study demonstrated that combining bupropion SR with venlafaxine, paroxetine, or fluoxetine in patients with sexual dysfunction from SSRI/SNRI monotherapy resulted in:
- 78% showing clinically significant benefit
- 33% achieving full response
- Significant improvement in sexual dysfunction (a common SSRI side effect that bupropion helps counteract) 2
Recent systematic review evidence (2025) indicates bupropion provides clinically relevant improvement in anxiety symptoms in adults with MDD, with generally comparable efficacy to SSRIs 3. A pilot trial also showed bupropion XL had comparable anxiolytic efficacy to escitalopram in generalized anxiety disorder 4.
Important Safety Considerations
Monitor for these specific issues when combining:
Seizure risk: Bupropion lowers seizure threshold. Avoid exceeding 450 mg/day total bupropion dose. Use caution if adding other medications that lower seizure threshold 1
Blood pressure: Both bupropion and SNRIs can increase blood pressure. Monitor BP before and during treatment 1
Activation/agitation: While bupropion doesn't typically worsen anxiety on validated measures 5, 3, initial activation can occur. The FDA label lists anxiety and agitation as common adverse reactions (5-7% incidence) 1. Starting SSRIs at subtherapeutic "test doses" can help assess tolerability 6
Drug interactions: Since bupropion inhibits CYP2D6, expect 2-3 fold increases in SSRI levels. Adjust doses accordingly 1
Practical Dosing Algorithm
- Continue current bupropion dose (typically 150-300 mg/day)
- Add SSRI at 50% of usual starting dose (e.g., sertraline 25 mg, paroxetine 10 mg, fluoxetine 10 mg)
- Titrate SSRI slowly over 1-2 week intervals for shorter half-life agents (sertraline) or 3-4 weeks for longer half-life agents (fluoxetine) 6
- Monitor for anxiety improvement starting at week 4—median time to clinically significant anxiolytic effect is 4 weeks 5
What NOT to Use
Avoid MAOIs with bupropion—this combination carries increased risk of hypertensive reactions and is contraindicated. Allow 14 days washout between stopping an MAOI and starting bupropion 1.
Use caution with benzodiazepines—abrupt discontinuation while on bupropion is contraindicated due to seizure risk 1.
The combination approach addresses both the norepinephrine/dopamine effects of bupropion and adds serotonergic activity for anxiety, while bupropion's profile helps counteract common SSRI side effects like sexual dysfunction and sedation 2.